Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Childs Nerv Syst ; 36(3): 621-628, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-31701280

RESUMEN

INTRODUCTION: Dolichoarteriopathies of the internal carotid artery (DICA) are frequent non-atheromatous anatomical changes in the general population. The etiology of DICA is still controversial: several hypotheses have been suggested, including an anomaly of embryological development, or a degenerative loss of elasticity of the vessel wall. DICA have been related to a wide spectrum of clinical presentations in adults, varying from asymptomatic forms to acute cerebrovascular events. However, to date, only a few pediatric cases have been reported. METHODS AND RESULTS: We report seven patients with DICA, 6 males and 1 female, aged 3 to 13 years, presenting with variable clinical symptoms. Different imaging techniques, including color Doppler ultrasound and magnetic resonance angiography, were used to show loops and/or kinking of the ICA. Three of these patients received a diagnosis of Ehlers-Danlos syndrome (EDS). DISCUSSION: This study highlights the clinical variability in pediatric patients with DICA. We emphasize the need for close clinical management of pediatric DICA. Finally, considering the long-term prognostic implications of EDS, we recommend specific testing in children with DICA and suspicious clinical signs of this pathology.


Asunto(s)
Enfermedades de las Arterias Carótidas , Síndrome de Ehlers-Danlos , Adulto , Arteria Carótida Interna/diagnóstico por imagen , Niño , Femenino , Humanos , Angiografía por Resonancia Magnética , Masculino , Ultrasonografía Doppler en Color
2.
Ital J Pediatr ; 47(1): 197, 2021 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-34593008

RESUMEN

BACKGROUND: Hypertrophic cardiomyopathy (HCM) in neonates is a rare and heterogeneous disorder. HCM accounts for 25 to 40% of all pediatric cardiomyopathy cases and the highest incidence in pediatric population is reported in children < 1 year. CASE PRESENTATION: we report two clinical cases of neonates, born to mothers respectively with a pre-pregnancy insulin-dependent diabetic mellitus type 2 and a suspected diabetes, with inadequate prenatal glycemic control for the first and underestimated glycemic control for the second case, with a different evolution. In the first case, a slow evidence of improvement of the HCM was observed, persuading us to the diagnosis of a diabetes-related HCM; In the second case the progressive worsening of the HCM during follow-up in association with further investigations, resulted in the diagnosis of Pompe disease. CONCLUSIONS: Hypertrophic cardiomyopathy in newborns can be the clinical expression of different underlying disorders. We aim to show the importance both to reassess maternal and family history and critically evaluate the physical examination in order to address the correct differential diagnosis. Furthermore it is important to continue a regular cardiologic follow-up for this pathology with neonatal onset to prevent a poor prognosis.


Asunto(s)
Cardiomiopatía Hipertrófica/diagnóstico , Enfermedad del Almacenamiento de Glucógeno Tipo II/diagnóstico , Embarazo en Diabéticas , Cardiomiopatía Hipertrófica/etiología , Diabetes Mellitus Tipo 2 , Femenino , Humanos , Recién Nacido , Embarazo
3.
Acta Biomed ; 91(11-S): e2020005, 2020 09 15.
Artículo en Inglés | MEDLINE | ID: mdl-33004775

RESUMEN

Available information suggests that anaphylaxis must be promptly recognized keeping in mind the airway patency, breathing (ventilation and respiration), circulation and mental status and treated. The first treatment is adrenaline. After successful treatment of an anaphylactic episode, attention must be paid to the prevention of early recurrences (biphasic anaphylaxis) and assessment of causes. Children should not be discharged before prescribing self-injectable adrenaline and explain how and under what circumstances it must be injected, An action plan must be communicated to their communities. Inform the school about potential reactions, how to prevent them and avoidance measures.


Asunto(s)
Anafilaxia , Anafilaxia/diagnóstico , Anafilaxia/tratamiento farmacológico , Anafilaxia/prevención & control , Niño , Epinefrina/uso terapéutico , Humanos , Alta del Paciente
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA